ACORD CADRU FURNIZARE MEDICAMENTE ONCOLOGIE 6
Buyer: SPITALUL JUDETEAN RESITA
- Published
- 20 November 2024
- Procedure
- Open procedure
- Notice number
- 00708932-2024
- Reference
- 57b787c3-eb1c-4c6b-920e-b6c15c292ce8
- Official source
- Official source
CPV codes
- 33652100Agentes antineoplásicos
Description
IObiectul procedurii de achiziţie publica îl constituie achizitia de produse farmaceutice – Medicamente PN ONCOLOGIE 6 care sunt necesare pentru desfasurarea in bune conditii a activitatii medicale specifice Spitalului Judetean de Urgenta- Sectiille oncologie si hemofilie(citostatice). Numar zile pana la care se pot solicita clarificari inainte de data limita de depunere a ofertelor/candidaturilor: 20 zile. Data limita de transmitere a raspunsului la solicitarile de clarificari: cu 11 zile inainte de data limita de depunere a ofertelor specificata in anuntul de participare.(Conform art.160 alin.2 si art.161 din Legea 98/2016 modificate prin OUG 107/2017).
Lots (56)
| Lot | Description | CPV code | Amount |
|---|---|---|---|
| 1 | Acidum clodronicum - 300mg/5ml -conc.pt.sol perf | 33652100 Agentes antineoplásicos | — |
| 2 | Acidum zoledronicum -4mg/ 5ml -conc.pt.sol perf | 33652100 Agentes antineoplásicos | — |
| 3 | Acidum zoledronicum -4mg/100ml- sol.perfuzabila | 33652100 Agentes antineoplásicos | — |
| 4 | Bendamustinum-2,5,g/ml-contine 100mg bendamustina - pulb.pt.conc.pt.sol.perf. | 33652100 Agentes antineoplásicos | — |
| 5 | Bendamustinum-2,5,g/ml-contine 25 mg bendamustina-pulb.pt.conc.pt.sol.perf. | 33652100 Agentes antineoplásicos | — |
| 6 | Bevacizumabum -25 mg/ ml - 16 ml concentrat (400mg)-conc.pt.sol perf | 33652100 Agentes antineoplásicos | — |
| 7 | Bevacizumabum-25 mg/ ml - 4 ml concentrat (100mg)-conc.pt.sol perf | 33652100 Agentes antineoplásicos | — |
| 8 | Bleomycinum sulfas-15mg (15000UI)-pulb.pt.conc.pt sol. Inj/ perf. | 33652100 Agentes antineoplásicos | — |
| 9 | Brentuximab vedotin-50mg-pulb.pt.conc.pt sol. perf. | 33652100 Agentes antineoplásicos | — |
| 10 | Carboplatinum -10mg/ml - 15 ml concentrat (150mg)-conc.pt.sol perf | 33652100 Agentes antineoplásicos | — |
| 11 | Carboplatinum -10mg/ml - 45 ml concentrat (450mg)-conc.pt.sol perf | 33652100 Agentes antineoplásicos | — |
| 12 | Cisplatinum -1mg/ml -10ml-conc.pt.sol perf | 33652100 Agentes antineoplásicos | — |
| 13 | Cisplatinum -1mg/ml -25ml-conc.pt.sol perf | 33652100 Agentes antineoplásicos | — |
| 14 | Cisplatinum -1mg/ml -100ml-conc.pt.sol perf | 33652100 Agentes antineoplásicos | — |
| 15 | Cladribinum- 2mg/ml -sol.inj | 33652100 Agentes antineoplásicos | — |
| 16 | Cytarabinum -20mg/ml-sol.inj./ perf. | 33652100 Agentes antineoplásicos | — |
| 17 | Cytarabinum - 100mg/ml- sol.inj./ perf. | 33652100 Agentes antineoplásicos | — |
| 18 | Dacarbazinum-200mg-pulb.pt.conc.pt.sol. perf. | 33652100 Agentes antineoplásicos | — |
| 19 | Daratumumabum-20mg/ml-20 ml concentrat (400mg)-conc.pt.sol perf | 33652100 Agentes antineoplásicos | — |
| 20 | Daratumumabum-120mg/ml -15ml sol-sol.inj | 33652100 Agentes antineoplásicos | — |
| 21 | Docetaxelum -10mg/ml-conc.pt.sol perf | 33652100 Agentes antineoplásicos | — |
| 22 | Docetaxelum-20mg/ml-conc.pt.sol perf | 33652100 Agentes antineoplásicos | — |
| 23 | Docetaxelum -80 mg/ 4ml-conc.pt.sol perf | 33652100 Agentes antineoplásicos | — |
| 24 | Doxorubicinum-2mg/ml -10ml concentrat-conc.pt.sol perf | 33652100 Agentes antineoplásicos | — |
| 25 | Doxorubicinum-50mg-pulb+amestec pt conc pt disp. lipozom. pt. perf | 33652100 Agentes antineoplásicos | — |
| 26 | Epirubicinum -2mg/ml - 10 ml sol.inj.x20mg (20mg/ 10ml)-sol.inj/ per. | 33652100 Agentes antineoplásicos | — |
| 27 | Epirubicinum -2mg/ml - 25 ml sol.inj.x50mg (50mg/ 25ml)-sol.inj/ per. | 33652100 Agentes antineoplásicos | — |
| 28 | Epirubicinum -2mg/ml - 50 ml sol.inj.x100mg (100mg/ 50ml)-sol.inj/ per. | 33652100 Agentes antineoplásicos | — |
| 29 | Filgrastimum -30MU/0,5 ml-sol.inj/ perf | 33652100 Agentes antineoplásicos | — |
| 30 | Filgrastimum -48MU/0,5 ml-sol.inj/ perf | 33652100 Agentes antineoplásicos | — |
Award criteria
- Price — Pretul cel mai scazut este singurul criteriu
Awards
| Awarded to | Amount | Date |
|---|---|---|
| ALLIANCE HEALTHCARE ROMÂNIA SRL | 16,986,902 RON | — |
| PHARMAFARM | 16,890,545 RON | — |
| ALLIANCE HEALTHCARE ROMÂNIA SRL | 8,255,491 RON | — |
| PHARMAFARM | 8,194,176 RON | — |
| PHARMAFARM | 8,194,176 RON | — |
| PHARMAFARM | 8,194,176 RON | — |
| PHARMAFARM | 8,194,176 RON | — |
| PHARMAFARM | 8,194,176 RON | — |
| ALLIANCE HEALTHCARE ROMÂNIA SRL | 3,648,542 RON | — |
| PHARMAFARM | 3,619,998 RON | — |
Official publications
- TED · 00708932-2024 · 20 November 2024
- OJS · 226/2024 · 20 November 2024
Other tenders from SPITALUL JUDETEAN RESITA
- ACORD-CADRU FURNIZARE substante antiseptice si dezinfectante
- ACORD-CADRU Servicii de colectare si eliminare a deseurilor spitalicesti inclusiv furnizare ambalaje de colectare
- Acord cadru furnizare materiale osteosinteza, implant ortopedic si proteze medicale
- Acord cadru furnizare consumabile medicale III
- Acord cadru furnizare - Consumabile si Solutii Hemodializa 2
- Acord cadru furnizare - Consumabile si Solutii Hemodializa 2
- Acord cadru furnizare medicamente PN 10
- Acord cadru furnizare medicamente PN 8
- ACORD CADRU furnizare medicamente PROGRAME NATIONALE
- ACORD-CADRU furnizare diverse materiale sanitare/echipamente de protectie
Frequently asked questions
- Who is the buyer of this tender?
- The contracting authority is SPITALUL JUDETEAN RESITA (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.